Cargando…

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction

Background: We aim to investigate the guideline adherence of β-blocker (BB) initiating dose in Chinese hospitalized patients with heart failure with reduced ejection fraction (HFrEF) and whether the adherence affected the in-hospital outcomes. Methods: This was a retrospective study of patients hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yiling, Zeng, Yuping, Wang, Si, Li, Nan, Wang, Miye, Mordi, Ify R., Ren, Yan, Zhou, Youlian, Zhu, Ye, Tian, Haoming, Sun, Xin, Chen, Xiaoping, An, Zhenmei, Lang, Chim C., Li, Sheyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660072/ https://www.ncbi.nlm.nih.gov/pubmed/34899323 http://dx.doi.org/10.3389/fphar.2021.770239

Ejemplares similares

Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study
por: Zhou, Yiling, et al.
Publicado: (2021)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
por: Mordi, Ify R., et al.
Publicado: (2020)

The combined incremental prognostic value of left ventricular ejection fraction, late gadolinium enhancement and global circumferential strain assessed by cardiovascular magnetic resonance
por: Mordi, Ify, et al.
Publicado: (2015)

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure
por: Steggall, Abbey, et al.
Publicado: (2017)

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
por: Mordi, Ify R., et al.
Publicado: (2019)

Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone: A case report
por: Li, Qianrui, et al.
Publicado: (2017)

Nicorandil‐induced colovesical fistula in a patient with diverticular disease
por: Noyes, James D., et al.
Publicado: (2021)

Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
por: Curran, Fraser M., et al.
Publicado: (2021)

Deficiencies in Planning Interventional Trial Registration of COVID-19 in China
por: Li, Xiaodan, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis
por: Yang, Han, et al.
Publicado: (2020)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial
por: Mordi, Natalie A., et al.
Publicado: (2020)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases
por: Mordi, Ify R., et al.
Publicado: (2020)

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

'Stress hyperglycemia ratio and in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes
por: Zhou, Yiling, et al.
Publicado: (2022)

Curative effect of β-blocker on various ejection fractions of patients with atrial fibrillation
por: Cao, Wei, et al.
Publicado: (2019)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

COVID-19-Associated Cardiovascular Complications
por: Lee, Clement C. E., et al.
Publicado: (2021)

Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
por: Mordi, Natalie A, et al.
Publicado: (2017)

Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
por: Li, Sheyu, et al.
Publicado: (2016)

β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction
por: Wang, Bin, et al.
Publicado: (2021)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Non-Invasive Imaging in Diabetic Cardiomyopathy
por: Mordi, Ify R.
Publicado: (2019)

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction
por: Wang, Bin, et al.
Publicado: (2021)

Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK
por: Mordi, Ify R., et al.
Publicado: (2020)

Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey
por: Liu, Chang, et al.
Publicado: (2021)

Thyroid Hormone Changes in Euthyroid Patients with Diabetes
por: Qin, Ken, et al.
Publicado: (2020)

A Comparison of Functional Features in Chinese and US Mobile Apps for Diabetes Self-Management: A Systematic Search in App Stores and Content Analysis
por: Wu, Yuan, et al.
Publicado: (2019)

Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes
por: Zhou, Yiling, et al.
Publicado: (2022)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
por: Mordi, Ify R, et al.
Publicado: (2017)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Bicuspid Aortic Valve Disease: A Comprehensive Review
por: Mordi, Ify, et al.
Publicado: (2012)

Evaluation of β-blocker therapy for long-term outcomes in patients with low ejection fraction after cardiac surgery
por: Fan, Fu-Dong, et al.
Publicado: (2020)

Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study
por: Mordi, Ify R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q3hokbhkvtlm0nj39hkarondvg